Probiotics Prevent Candida Colonization and Invasive Fungal Sepsis in Preterm Neonates: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Pediatrics and Neonatology

Volumn 58, Issue 2, 2017, Pages 103-110

  Hu, Hua Jian ^a   Zhang, Guo Qiang ^a   Zhang, Qiao ^a   Shakya, Shristi ^a   Li, Zhong Yue ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Candida colonization; invasive fungal sepsis; meta analysis; preterm; probiotics

Indexed keywords

PROBIOTIC AGENT;

CANDIDEMIA; DRUG EFFECT; FUNGAL COLONIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INVASIVE CANDIDIASIS; META ANALYSIS; NEWBORN; NONHUMAN; PRACTICE GUIDELINE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CANDIDIASIS; DIETARY SUPPLEMENT; MICROBIOLOGY; NEONATAL SEPSIS;

CANDIDIASIS; DIETARY SUPPLEMENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NEONATAL SEPSIS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84993995189     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2016.06.001     Document Type: Review

References (57)

1. 1 Manzoni, P., Use of Lactobacillus casei subspecies rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates. J Pediatr Gastroenterol Nutr 45 (2007), S190–S194.
2. 2 Dong, Y., Speer, C.P., Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed 100 (2015), F257–F263.
3. 3 Tsai, M.H., Hsu, J.F., Chu, S.M., Lien, R., Huang, H.R., Chiang, M.C., et al. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 33 (2014), e7–e13.
4. 4 Shane, A.L., Stoll, B.J., Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 30 (2013), 131–141.
5. 5 Filioti, J., Spiroglou, K., Panteliadis, C.P., Roilides, E., Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 33 (2007), 1272–1283.
6. 6 Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110 (2002), 285–291.
7. 7 Tezer, H., Canpolat, F.E., Dilmen, U., Invasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis. Expert Opin Pharmacother 13 (2012), 193–205.
8. 8 Spiliopoulou, A., Dimitriou, G., Jelastopulu, E., Giannakopoulos, I., Anastassiou, E.D., Christofidou, M., Neonatal intensive care unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series. Mycopathologia 173 (2012), 219–228.
9. 9 Ali, G.Y., Algohary, E.H., Rashed, K.A., Almoghanum, M., Khalifa, A.A., Prevalence of Candida colonization in preterm newborns and VLBW in neonatal intensive care unit: role of maternal colonization as a risk factor in transmission of disease. J Matern Fetal Neonatal Med 25 (2012), 789–795.
10. 10 Adams-Chapman, I., Bann, C.M., Das, A., Goldberg, R.N., Stoll, B.J., Walsh, M.C., et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr 163 (2013), 961–967.
11. 11 Cerikçioğlu, N., Ilki, A., Bilgen, H., Ozek, E., Metin, F., Kalaça, S., The relationships between candidemia and candidal colonization and virulence factors of the colonizing strains in preterm infants. Turk J Pediatr 46 (2004), 245–250.
12. 12 Manzoni, P., Farina, D., Antonielli d'Oulx, E., Leonessa, M.L., Gomirato, G., Arisio, R., An association between anatomic site of Candida colonization and risk of invasive candidiasis exists also in preterm neonates in neonatal intensive care unit. Diagn Microbiol Infect Dis 56 (2006), 459–460.
13. 13 Vendettuoli, V., Tana, M., Tirone, C., Posteraro, B., La Sorda, M., Fadda, G., et al. The role of Candida surveillance cultures for identification of a preterm subpopulation at highest risk for invasive fungal infection. Pediatr Infect Dis J 27 (2008), 1114–1116.
14. 14 Singhi, S., Rao, D.S., Chakrabarti, A., Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 9 (2008), 91–95.
15. 15 Saiman, L., Ludington, E., Dawson, J.D., Patterson, J.E., Rangel-Frausto, S., Wiblin, R.T., et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20 (2001), 1119–1124.
16. 16 Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356 (2007), 2483–2495.
17. 17 Manzoni, P., Mostert, M., Latino, M.A., Pugni, L., Stolfi, I., Decembrino, L., et al. Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT. Early Hum Dev 88 (2012), S60–S64.
18. 18 Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., Grossman, L.B., Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 147 (2005), 172–179.
19. 19 Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., Donowitz, L.G., Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345 (2001), 1660–1666.
20. 20 Sims, M.E., Yoo, Y., You, H., Salminen, C., Walther, F.J., Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 5 (1988), 33–36.
21. 21 Ganesan, K., Harigopal, S., Neal, T., Yoxall, C.W., Prophylactic oral nystatin for preterm babies under 33 weeks’ gestation decreases fungal colonisation and invasive fungaemia. Arch Dis Child Fetal Neonatal Ed 94 (2009), F275–F278.
22. 22 Joint FAO-WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the evaluation of probiotics in food: report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food, London, Ontario, Canada, April 30 and May 1, 2002. Available at ftp://ftp.fao.org/es/esn/food/wgreport2.pdf. [Accessed September 17, 2016].
23. 23 Villena, J., Salva, S., Agüero, G., Alvarez, S., Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 55 (2011), 434–445.
24. 24 Samonis, G., Falagas, M.E., Lionakis, S., Ntaoukakis, M., Kofteridis, D.P., Ntalas, I., et al. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut. Med Mycol 49 (2011), 395–399.
25. 25 Matsubara, V.H., Silva, E.G., Paula, C.R., Ishikawa, K.H., Nakamae, A.E., Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis 18 (2012), 260–264.
26. 26 Ishijima, S.A., Hayama, K., Burton, J.P., Reid, G., Okada, M., Matsushita, Y., et al. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78 (2012), 2190–2199.
27. 27 Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151 (2009), W65–W94.
28. 28 Higgins, J.P., Green, S., Cochrane handbook for systematic reviews of interventions. version 5.1.0 [updated March 2011], 2011, The Cochrane Collaboration Available at http://handbook.cochrane.org [Accessed September 17, 2016].
29. 29 Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
30. 30 Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
31. 31 Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
32. 32 Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
33. 33 Kumar, S., Bansal, A., Chakrabarti, A., Singhi, S., Evaluation of efficacy of probiotics in prevention of Candida colonization in a PICU–a randomized controlled trial. Crit Care Med 41 (2013), 565–572.
34. 34 Manzoni, P., Stolfi, I., Messner, H., Cattani, S., Laforgia, N., Romeo, M.G., et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 129 (2012), 116–123.
35. 35 Manzoni, P., Rinaldi, M., Cattani, S., Pugni, L., Romeo, M.G., Messner, H., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 302 (2009), 1421–1428.
36. 36 Al-Hosni, M., Duenas, M., Hawk, M., Stewart, L.A., Borghese, R.A., Cahoon, M., et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 32 (2012), 253–259.
37. 37 Manzoni, P., Mostert, M., Leonessa, M.L., Priolo, C., Farina, D., Monetti, C., et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 42 (2006), 1735–1742.
38. 38 Oncel, M.Y., Sari, F.N., Arayici, S., Guzoglu, N., Erdeve, O., Uras, N., et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 99 (2014), F110–F115.
39. 39 Romeo, M.G., Romeo, D.M., Trovato, L., Oliveri, S., Palermo, F., Cota, F., et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 31 (2011), 63–69.
40. 40 Roy, A., Chaudhuri, J., Sarkar, D., Ghosh, P., Chakraborty, S., Role of enteric supplementation of probiotics on late-onset sepsis by Candida species in preterm low birth weight neonates: a randomized, double blind, placebo-controlled trial. N Am J Med Sci 6 (2014), 50–57.
41. 41 Sari, F.N., Dizdar, E.A., Oguz, S., Erdeve, O., Uras, N., Dilmen, U., Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 65 (2011), 434–439.
42. 42 Hikaru, U., Koichi, S., Yayoi, S., Hiromichi, S., Hiroaki, S., Yoshikazu, O., et al. Bifidobacteria prevents preterm infants from developing infection and sepsis. Int J Probiotics Prebiotics 5 (2010), 33–36.
43. 43 Wagner, R.D., Pierson, C., Warner, T., Dohnalek, M., Farmer, J., Roberts, L., et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 65 (1997), 4165–4172.
44. 44 Wagner, R.D., Pierson, C., Warner, T., Dohnalek, M., Hilty, M., Balish, E., Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 63 (2000), 638–644.
45. 45 Oncel, M.Y., Arayici, S., Sari, F.N., Simsek, G.K., Yurttutan, S., Erdeve, O., et al. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. J Matern Fetal Neonatal Med 28 (2015), 1790–1794.
46. 46 Demirel, G., Celik, I.H., Erdeve, O., Saygan, S., Dilmen, U., Canpolat, F.E., Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. Eur J Pediatr 172 (2013), 1321–1326.
47. 47 Murina, F., Graziottin, A., Vicariotto, F., De Seta, F., Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: a clinical study. J Clin Gastroenterol 48 (2014), S102–S105.
48. 48 Martinez, R.C., Franceschini, S.A., Patta, M.C., Quintana, S.M., Candido, R.C., Ferreira, J.C., et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48 (2009), 269–274.
49. 49 Ehrström, S., Daroczy, K., Rylander, E., Samuelsson, C., Johannesson, U., Anzén, B., et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect 12 (2010), 691–699.
50. 50 Campeotto, F., Suau, A., Kapel, N., Magne, F., Viallon, V., Ferraris, L., et al. A fermented formula in preterm infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br J Nutr 105 (2011), 1843–1851.
51. 51 Grönlund, M.M., Arvilommi, H., Kero, P., Lehtonen, O.P., Isolauri, E., Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0–6 months. Arch Dis Child Fetal Neonatal Ed 83 (2000), F186–F192.
52. 52 Ahrne, S., Hagslatt, M.L., Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3 (2011), 104–117.
53. 53 Hardy, H., Harris, J., Lyon, E., Beal, J., Foey, A.D., Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5 (2013), 1869–1912.
54. 54 Frei, R., Akdis, M., O'Mahony, L., Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol 31 (2015), 153–158.
55. 55 Zhang, G.Q., Hu, H.J., Liu, C.Y., Shakya, S., Li, Z.Y., Probiotics for preventing late-onset sepsis in preterm neonates: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 95, 2016, e2581.
56. 56 AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev(4), 2014, CD005496.
57. 57 Wheeler, K.E., Cook, D.J., Mehta, S., Calce, A., Guenette, M., Perreault, M.M., et al. Use of probiotics to prevent ventilator-associated pneumonia: a survey of pharmacists’ attitudes. J Crit Care 31 (2016), 221–226.